The firm's goal for its SeekIt platform is to combine the accessibility of antibody and antigen testing and the accuracy of PCR for use in low-resource settings.

The technology can more effectively test for antibiotic susceptibility in heteroresistant bacterial populations than existing approaches.

TBI is a potential new application area for the 8-year-old company, while it continues to commercialize its stroke triage ...

The US Food and Drug Administration granted clearances for PCR-based infectious disease tests from multiple entities as well as other in vitro diagnostic tests.

The new ruling reverses a jury verdict from four years ago that handed ArcherDx, which no longer exists, $4.7 million in damages.

The firm said that it will use the money for working capital and general corporate purposes, and the raise follows a $3.25 million public offering that closed in May.

ArteraAI Prostate is authorized for use as a tool to prognosticate long-term outcomes for patients with non-metastatic prostate cancer.

Last week, readers were most interested in a story about Diasorin's preparation to enter the point-of-care molecular testing space with a benchtop instrument.

NEW YORK – The World Health Organization on Monday released an update to its operational handbook on the diagnosis of tuberculosis that provides laboratory personnel, clinicians, ministries of health, ...